Jill Feldman, Co-Founder of EGFR Resister, shared a post on X:
“Calling all Thoracic Oncology leaders!
We’re inviting early career investigators to submit an abstract for a chance to join us at the 7th Annual EGFR Resisters Research Summit, (Nov 6–8 in Chicago).
Please share this opportunity with your fellows, postdocs, or junior faculty who are eager to connect with experts in EGFR NSCLC, network with colleagues and patient advocates to advance the science.
Deadline: August 8th
Submit abstracts here.”
More posts featuring Jill Feldman on OncoDaily.